Tag: lifesciences

New Delhi: Zydus Lifesciences on Wednesday has received approval from the US health regulator to market a generic diabetes drug in the US market.The company has received tentative approval ...

Cohance Lifesciences on Tuesday announced a strategic investment of USD 10 million (around Rs 87.6 crore) to expand bioconjugation capabilities at its US-based subsidiary, NJ Bio.The investment advances Cohance's ...

Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets. The tentative ...

NEW DELHI: Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the generic version of cholesterol lowering Niacin extended-release tablets.The ...

Zydus Lifesciences on Monday acquired 6.5 per cent in Mylab Discovery Solutions from Rising Sun Holding Private Limited for Rs 106 crore, the company said in a press release. ...

Bangalore: HFS Research has released a report in collaboration with Indegene, elaborating how Generative AI (GenAI) can turbocharge lifesciences growth if choices are selective and deliberate. The report offers ...

Zydus Lifesciences on Friday said it has received a warning letter from USFDA relating to its injectables manufacturing facility at Jarod near Vadodara. The warning letter is an escalation ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market a generic medication to treat Parkinson's disease. The company has received approval from ...

Paris: The majority (63 per cent) of lifesciences organisations, across biopharma and MedTech, have connected health products already on the market or under development. Irrespective of their stage of ...

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulatory for its generic version of cancer treatment drug Cyclophosphamide capsules. The approval by ...